A 36-year-old Japanese woman took over-the-counter (OTC) medication for headaches for 20 days. Subsequently, five days after discontinuing the medication, a skin rash developed over the patient's upper and lower limbs and face, in addition to a fever, brown urine and serious liver dysfunction. Drug lymphocyte stimulation tests implicated ibuprofen, a main component of the OTC drugs, which has the potential to induce this pathology, and a diagnosis of drug-induced liver injury with multiform exudative erythema was made. The patient's symptoms and liver function tests returned to normal following treatment with systemic steroids.
Introduction
Drug-induced liver injury (DILI) is a major cause of acute liver injury. The incidence of this condition is currently increasing in parallel with the increase in the number of new drugs available on the market (1) . In addition to prescription medications, dietary supplements and/or over-the-counter (OTC) drugs can induce liver injury to a greater extent than previously thought.
DILI can be classified into two different types: predictable direct toxicity and unpredictable idiosyncratic toxicity (2) . The idiosyncratic type is further subclassified as involving an allergic (or hypersensitivity) reaction, presenting with extrahepatic manifestations, such as fever, rashes, eosinophilia and other forms of organ damage, or nonallergic (or metabolic) reaction, in which there are no extrahepatic manifestations (3, 4) . The frequency of the allergictype DILI has recently decreased (5) . However, the liver is the most commonly involved internal organ in patients with drug-induced systemic hypersensitivity, and liver dysfunction is the major cause of death in those with certain phenotypes of drug hypersensitivity (6, 7) .
In this report, we describe a very rare case of severe allergic-type DILI caused by the consumption of an OTC drug containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen complicated by systemic hypersensitivity and multiform exudative erythema.
Case Report
A 36-year-old Japanese woman presented to a local hospital with a fever, skin rash and brown urine. She had been taking an OTC medication containing ibuprofen as the main component occasionally for intermittent headaches. However, the frequency of the patient's headaches increased, and her consumption of the OTC agent had consequently increased to four times a day during the last 20 days prior to symptom onset. The drug was ultimately discontinued due to epigastric pain, and the patient began to take famotidine, azulene sodium sulfonate and domperidone, as prescribed by a local doctor. Five days after the discontinuation of the OTC medication (25 days after its initiation), the patient was admitted to a local hospital for treatment of a fever, rash and brown urine. The skin rash was advanced and severe liver dysfunction was detected; therefore, she was referred and admitted to our hospital. On admission, the patient's temperature was 39 , and erythema was observed on her upper and lower limbs and face, spreading over a large area (Fig. 1) . The admission laboratory data are summarized in Table 1 . The serum levels of transaminases and total bilirubin were increased, and the prothrombin time was prolonged. In addition, the serum level of immunoglobulin (Ig) E was elevated. Neither liver atrophy nor ascites were evident on ultrasonography or computed tomography. The serum NH3 level was slightly high; however, no symptoms of hepatic encephalopathy (such as loss of consciousness or flapping tremors) were observed. Tests for hepatitis B surface antigens, IgM anti-hepatitis B core antibodies, antihepatitis C antibodies and other viral serological markers, including human herpes virus-6 (HHV-6), were negative, as was the titer of antinuclear antibodies. Drug lymphocyte stimulation tests (DLSTs) were performed to identify drugs and/or components causative of the patient's allergic reaction (Table 2) ; the only positive result was for ibuprofen (Table 2) . Hence, a preliminary diagnosis of DILI was made, and a liver biopsy was performed 14 days after the discontinuation of the drug (Fig. 2) . Consequently, collapse of hepatocytes was observed, primarily around centrilobular areas, with infiltration of various kinds of inflammatory cells. The skin lesion was diagnosed as multiform exudative erythema, and a definitive diagnosis of allergic-type DILI caused by ibuprofen complicated by systemic hypersensitivity and multiform exudative erythema was made.
Due to the persistence of liver injury despite the discontinuation of the causative drug, 1,000 mg of methylprednisolone was administered intravenously daily for three days, followed by a tapered course of an oral corticosteroid. Subsequently, the rash resolved and the liver function tests returned to normal within four weeks (Fig. 3) .
Discussion
In addition to acetaminophen and aspirin, ibuprofen is a best-selling OTC drug. Traversa et al. reported that, in a cohort study of thousands of patients taking various NSAIDs, ibuprofen was found to have a very low rate of liver toxicity, despite the massive use of this drug worldwide (8) . Furthermore, several other studies and meta-analyses have failed to include severe liver injury as a side effect of ibuprofen use (9, 10) . Taken together, these findings suggest that ibuprofen is an uncommon cause of liver injury.
The current patient had been taking an OTC agent containing ibuprofen for the symptomatic treatment of headaches. The time until onset of liver injury, as well as the exclusion of other causes of hepatitis and the patient's liver biopsy findings and DLST results, indicated a diagnosis of DILI. In addition, the score according to the diagnostic scale of the DDW-J 2004 workshop (11) was 8 or "highly probable." Moreover, the patient's clinical symptoms and liver function tests completely resolved following the discontinuation of the OTC medication and initiation of corticosteroids.
Drug-induced systemic hypersensitivity reactions involve the development of a rash in response to the consumption of a drug accompanied by the dysfunction of any internal organ (12) . In a prospective study of patients with severe forms of maculopapular exanthema, approximately 20% exhibited elevation of liver enzymes (13) . Internal organ dysfunction may develop in the context of various phenotypes of drug hypersensitivity, including drug reactions with eosinophilia and systemic symptoms (DRESS), drug-induced hypersensitivity (DiHS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute generalized exanthematous pustulosis and even maculopapular rashes (12, 14, 15) . Lee et al. (16) analyzed 136 patients with drug-induced systemic hypersensitivity associated with liver dysfunction and found DRESS/DiHS and SJS/TEN to be the most frequent phenotypes, whereas erythema multiforme was noted in only 2% of the patients. Erythema multiforme is characterized by the centrifugal spread of erythema annular lesions with typical depressed areas referred to as target lesions and/or increased regions of reddening in the center of the erythematous zone referred to as iris formation. Erythema multiforme may shift to SJS/TEN. Meanwhile, SJS consists of areas of enanthema and/or skin erythema at mucocutaneous junctions, such as the inner lip, conjunctiva or external genitalia, along with regions of hydroa or erosion. Of the various types of systemic drug hypersensitivity reactions, TEN is the most severe, with regions of hydroa or erosion covering more than 10% of the patient's body. With respect to NSAIDs, a case of an erythema multiforme-type eruption caused by celecoxib has been reported; however, liver injury was not detected (17) . For drugs other than NSAIDs, ethambutol-induced erythema multiforme-type eruptions associated with liver injury have been documented (18) , although the liver injury was not as severe as that observed in the current case. DRESS is a severe adverse drug-induced reaction associated with potentially life-threatening symptoms, such as severe skin rashes, fever, hematological abnormalities and internal organ involvement (14) . Most affected patients have eosinophilia or activated T cells (atypical lymphocytes), often in the peripheral blood (6) . The current patient had neither of these symptoms, and the diagnosis of DRESS was ruled out based on the scoring system for classifying DRESS (19) . In some patients with drug-induced systemic hypersensitivity reactions, HHV-6 reactivation is detected during the third or fourth weeks of the disease; Tohyama et al. described this pathological entity as DiHS (15, 20) . DiHS is similar to DRESS; however, DiHS is characterized or defined by viral reactivation, particularly with HHV-6. The number of culprit drugs is limited, including carbamazepine, phenytoin, phenobarbital, zonisamide, allopurinol, salazosulfapyridine, diaphenylsulphone and mexiletine (15) . The current patient did not use such drugs, and HHV-6 DNA was not detected in her serum. Moreover, the titer of IgG anti-HHV6 antibodies was not elevated on admission or after 30 days, indicating that the diagnosis of DiHS can also be excluded. The culprit drug in this case was the OTC medication. NSAIDs are very frequently used in daily life. Therefore, it is clinically important to identify similar drugs with the potential to cause liver injury. DLST are thus a useful tool for identifying culprit drugs causative of DILI, particularly in allergic-type DILI patients (21, 22) . The results of DLSTs for typical NSAIDs other than ibuprofen in the present case are shown in Table 3 . Considering these data, we strongly suggest that the use of drugs containing agents positive on DLST should therefore be avoided in the future.
In a retrospective survey of Japanese cases of DILI (23), the incidence of skin rashes was decreased compared to that observed in previous studies. However, some DILI patients with skin rashes have been reported to progress to severe liver injury, even fulminant hepatitis requiring liver transplantation. Therefore, DLST is useful for obtaining a definitive diagnosis and the prompt use of steroids is important for preventing serious complications in patients with DILI, even those with severe skin rashes. To summarize, clinicians should keep in mind the potential for liver dysfunction and/ or systemic symptoms in patients using OTC medications containing ibuprofen.
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